한글목차

레드 바이오테크놀러지 시장은 2025년 9,102억 6,000만 달러, 2032년에는 1조 8,543억 8,000만 달러에 이를 것으로 예측되며, 2025-2032년 연평균 복합 성장률(CAGR)은 10.7%를 나타낼 전망입니다.

레드 바이오테크놀러지는 의료 바이오테크놀러지로도 알려져 있으며, 의료 및 헬스케어 용도에 특화된 바이오테크놀러지의 하위 분야입니다. 질병 치료 및 예방을 위한 신약, 치료법, 의료 기술 개발에 생명공학 기술을 활용합니다.

시장 역학:

레드 바이오테크 시장은 몇 가지 요인에 의해 주도되고 있습니다. 고령화, 만성질환 증가, 팬데믹으로 인한 세계 헬스케어 수요 증가 등이 그것입니다. 유전체학, 개인 맞춤형 의료, 유전자 치료의 발전도 주요 촉진요인입니다. 또한, 정부 투자, 규제 당국의 지원, 민간 부문의 관심 증가도 혁신적인 치료법과 치료법을 개발하려는 레드 바이오테크놀러지의 성장에 기여하고 있습니다.

그러나 생물학적 제제의 의약품 개발과 관련된 높은 비용이 시장 성장을 억제할 것으로 예측됩니다.

본 조사의 주요 특징

• 세계의 레드 바이오테크놀러지(Red Biotechnology) 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR)을 조사하여 정리한 보고서입니다.
• 또한, 다양한 부문에 걸친 잠재적 수익 기회를 파악하고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 레드 바이오테크놀러지 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 레드 바이오테크 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 레드 바이오테크놀러지 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 발매 및 승인
• PEST 분석
• PORTER 분석
• 인수합병(M&A) 시나리오

제4장 세계의 레드 바이오테크놀러지 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 세계의 레드 바이오테크놀러지 시장, 제품 유형별, 2020-2032년

• 바이오의약품
• 바이오시밀러
• 유전자 치료
• 조직공학
• 세포 치료

제6장 세계의 레드 바이오테크놀러지 시장, 용도별, 2020-2032년

• Drug Discovery & Development
• 동물 바이오테크놀러지
• 환경 바이오테크놀러지
• 의료 바이오테크놀러지
• 산업 바이오테크놀러지
• 농업 생명공학
• 기타

제7장 세계의 레드 바이오테크놀러지 시장, 최종사용자별, 2020-2032년

• 제약 및 바이오의약품 기업
• 연구기관
• 바이오테크놀러지 산업
• 병원 및 진단센터
• 학술기관

제8장 세계의 레드 바이오테크놀러지 시장, 지역별, 2020년-2032년

• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 영국
  • 스페인
  • 프랑스
  • 이탈리아
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 호주
  • 한국
  • ASEAN
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 아르헨티나
  • 멕시코
  • 기타 라틴아메리카
• 중동
  • GCC 국가
  • 이스라엘
  • 기타 중동
• 아프리카
  • 남아프리카
  • 북아프리카
  • 중앙아프리카

제9장 경쟁 구도

• Amgen Inc.
• Gilead Sciences, Inc.
• Biogen
• Pfizer Inc.
• Novartis AG
• Hoffmann-La Roche
• Johnson & Johnson Services, Inc.
• Sanofi
• Merck & Co. Inc.
• AbbVie Inc.
• GSK plc.
• AstraZeneca
• Eli Lilly and Company
• Novo Nordisk A/S
• Bayer AG
• Bristol-Myers Squibb Company
• Teva Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company Limited
• Boehringer Ingelheim International GmbH
• Astellas Pharma Inc.

제10장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Red Biotechnology Market is estimated to be valued at USD 910.26 Bn in 2025 and is expected to reach USD 1,854.38 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.7% from 2025 to 2032.

Red biotechnology, also known as medical biotechnology, is a subsector of biotechnology that focuses on medical and healthcare applications. It involves the use of biotechnology techniques to develop new drugs, therapies, and medical technologies for the treatment and prevention of diseases.

Market Dynamics:

Red biotechnology market is driven by several factors. These include the increasing global healthcare needs due to aging populations, rising chronic diseases, and pandemics. Advances in genomics, personalized medicine, and gene therapies are also key drivers. Additionally, government investments, regulatory support, and growing private sector interest contribute to the growth of red biotechnology, which aims to develop innovative medical treatments and therapies.

However, high costs associated with biologics drug development is expected to restrain the market growth.

Key features of the study:

• This report provides in-depth analysis of the global red biotechnology market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global red biotechnology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Amgen, Gilead Sciences, Biogen, Pfizer, Novartis, Roche, Johnson & Johnson, Sanofi, Merck & Co., AbbVie, GlaxoSmithKline, AstraZeneca, Eli Lilly, Novo Nordisk, Bayer, Bristol-Myers Squibb, Teva Pharmaceutical, Takeda Pharmaceutical, Boehringer Ingelheim, and Astellas Pharma
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global red biotechnology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global red biotechnology market

Red Biotechnology Market Detailed Segmentation:

• By Product Type
  • Biopharmaceuticals
  • Biosimilars
  • Gene Therapy
  • Tissue Engineering
  • Cell Therapy
• By Application
  • Drug Discovery & Development
  • Animal Biotechnology
  • Environmental Biotechnology
  • Medical Biotechnology
  • Industrial Biotechnology
  • Agricultural Biotechnology
  • Others
• By End User
  • Pharmaceutical & Biopharmaceutical Companies
  • Research Institutes
  • Biotechnology Industry
  • Hospitals & Diagnostic Centers
  • Academic Institutions
• Company Profiles
  • Amgen
  • Gilead Sciences
  • Biogen
  • Pfizer
  • Novartis
  • Roche
  • Johnson & Johnson
  • Sanofi
  • Merck & Co.
  • AbbVie
  • GlaxoSmithKline
  • AstraZeneca
  • Eli Lilly
  • Novo Nordisk
  • Bayer
  • Bristol-Myers Squibb
  • Teva Pharmaceutical
  • Takeda Pharmaceutical
  • Boehringer Ingelheim
  • Astellas Pharma

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Application
  • Market Snippet , By End User
  • Market Snippet , By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing prevalence of chronic diseases
  • Pricing pressures on biologics
  • Biotech applications in agriculture
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Red Biotechnology Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Red Biotechnology Market, By Product Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Biopharmaceuticals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Biosimilars
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Gene Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Tissue Engineering
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Cell Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Red Biotechnology Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Drug Discovery & Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Animal Biotechnology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Environmental Biotechnology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Medical Biotechnology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Industrial Biotechnology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Agricultural Biotechnology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Red Biotechnology Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pharmaceutical & Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Biotechnology Industry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Hospitals & Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Academic Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Red Biotechnology Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Amgen Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Gilead Sciences, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Biogen
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Hoffmann-La Roche
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Johnson & Johnson Services, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Merck & Co. Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• AbbVie Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• GSK plc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• AstraZeneca
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Eli Lilly and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Novo Nordisk A/S
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bristol-Myers Squibb Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Takeda Pharmaceutical Company Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Boehringer Ingelheim International GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Astellas Pharma Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us